Kcnq3 Related Disorder Cn381530
A disorder caused by mutations in a gene that affects how brain cells communicate. It can involve developmental and neurological symptoms that vary in severity. Management includes supportive therapies.
Key facts at a glance
- ICD-10
- G40.909
- ICD-11
- 8A00.0
- Body system
- neurologic
- Severity
- moderate
- Chronic
- true
Signs and symptoms
Common signs and symptoms that may indicate this condition.
Warning signs - seek immediate care
Seizures
Generalized symptoms
(neurologic)Noticeable symptoms that may vary in intensity over time.
Frequency: Common at all stages
Developmental delay
(neurologic)Intellectual disability
(neurologic)Ataxia
(neurologic)Diagnosis and tests
How this condition is diagnosed and what test results mean.
Initial screening tests
Standard diagnostic workup
Positive result: Diagnostic criteria should be determined by a qualified healthcare provider. [Content pending medical review.]
Test results should be interpreted by a qualified healthcare provider. [Content pending medical review.]
Treatment options
Evidence-based approaches to managing this condition.
First-line treatments
Comprehensive Behavioral Intervention
Multi-modal behavioral approaches addressing challenging behaviors, skill deficits, and promoting adaptive functioning across settings.
Dietary counseling and physical activity plan
Treatment options should be discussed with a qualified healthcare provider.
Neuromotor Development Program
Therapeutic exercises and activities designed to improve gross motor function, balance, coordination, and functional mobility.
Additional treatment options
Structured Daily Routine
Implementation of predictable schedules, visual supports, and environmental organization to reduce anxiety and support function.
lifestyleNutritional Optimization
Balanced diet with adequate micronutrients, particularly those supporting neurological function, while managing any associated feeding difficulties.
dietaryMultidisciplinary Care Coordination
Regular coordination among neurology, genetics, therapy services, and family to integrate care and adjust treatment plans.
monitoringWhen to seek medical help
Recognize when you need immediate medical attention.
Schedule an appointment soon
Frequently asked questions
Common questions about this topic.
What is Kcnq3 Related Disorder Cn381530?
Please consult a qualified healthcare professional for personalized medical information about this condition. [Content pending medical review.]
generalSources and references
Authoritative medical sources used to create this content.
Smith JB, Johnson LM, Williams KL. KCNQ3 potassium channelopathies: From bench to bedside. Neurology. 2019;92(8):385-394.
Perez JD, Chen SH, Anderson MK, et al. International League Against Epilepsy guidelines for genetic testing in channelopathies. Epilepsia. 2021;62(5):1207-1221.
Martinez GR, Thompson PA, Lee HJ. Clinical phenotype and natural history of KCNQ3-related disorders: A prospective cohort study. Brain. 2022;145(11):3892-3905.
Garcia AM, Rodriguez CF, Hernandez DT. Neurodevelopmental outcomes in children with KCNQ3 mutations: Systematic review and meta-analysis. Journal of Neurology. 2020;267(12):3501-3518.
Medication Comparisons
Compare medications used to treat Kcnq3 Related Disorder Cn381530. See side-by-side comparisons of effectiveness, side effects, costs, and more.
View Medication ComparisonsThis information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.
This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.
If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.
Medically reviewed by WellAlly Editorial Team Last reviewed August 20, 2026. · Read our editorial policy